Emerging Market Entry and Investigations

May 10, 2024 4:30pm

Maria Villanueva Sessions
Director, Ethics & Compliance
BioTissue

Juan Luis Fuentes
Director, Healthcare Compliance, Government Affairs & Policy
Johnson & Johnson

Angela Main
Senior Vice President, Global Chief Compliance Officer & Associate General Counsel, Asia Pacific
Zimmer Biomet (USA)

  • The corruption landscape in key emerging markets, including recent headlines and scandals
  • China’s new laws and regulations aimed at both bribe payors and recipients
  • India’s slew of legislative and regulatory developments impacting compliance requirements and investigative procedures
  • Africa’s anti-corruption enforcement trends and how they are threatened by an uptick in political transitions
  • The importance of including key contractual provisions and audit rights and mechanisms